ASPEN AEROGELS, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$41M
↓-66.4% -$82Mvs FY2024 (Q4)
Gross Profit
$0
↓-100.0% -$47Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $41M | $123M |
| COGS | $41M | $76M |
| Gross Profit | $0 | $47M |
| R&D | $3M | $4M |
| SG&A | $0 | $0 |
| D&A | $28M | $5M |
| Other OpEx | $0 | $23M |
| Operating Income | $0 | $15M |
| Interest Exp. | $0 | $4M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $11M |
| Tax | $0 | $0 |
| Net Income | $0 | $11M |
QuarterCharts · SEC EDGAR data · ASPN · Comparing FY2025 (Q4) vs FY2024 (Q4)